AR032050A1 - Metodo para identificar ligandos de receptores de progesterona especificos para isoformas y ligandos de receptores de progesterona selectivos para tejidos - Google Patents
Metodo para identificar ligandos de receptores de progesterona especificos para isoformas y ligandos de receptores de progesterona selectivos para tejidosInfo
- Publication number
- AR032050A1 AR032050A1 ARP010106030A ARP010106030A AR032050A1 AR 032050 A1 AR032050 A1 AR 032050A1 AR P010106030 A ARP010106030 A AR P010106030A AR P010106030 A ARP010106030 A AR P010106030A AR 032050 A1 AR032050 A1 AR 032050A1
- Authority
- AR
- Argentina
- Prior art keywords
- progesterone
- isoforms
- legends
- selective
- specific
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25831200P | 2000-12-28 | 2000-12-28 | |
US30587501P | 2001-07-18 | 2001-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR032050A1 true AR032050A1 (es) | 2003-10-22 |
Family
ID=26946565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010106030A AR032050A1 (es) | 2000-12-28 | 2001-12-26 | Metodo para identificar ligandos de receptores de progesterona especificos para isoformas y ligandos de receptores de progesterona selectivos para tejidos |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1373888A2 (no) |
JP (1) | JP2004516841A (no) |
AR (1) | AR032050A1 (no) |
AU (1) | AU2002219218A1 (no) |
NO (1) | NO20032969L (no) |
PE (1) | PE20020784A1 (no) |
UY (1) | UY27107A1 (no) |
WO (1) | WO2002054064A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04008881A (es) * | 2002-03-11 | 2004-12-07 | Schering Ag | 5-{2- hidroxi-3 -[1-(3- trifluorometilfenil) -ciclopropil] -propionilamino}- ftalida y compuestos relacionados con actividad que modula el receptor de progesterona para utilizarse en control de fertilidad y terapia de reemplazo hormonal. |
DE102007023614A1 (de) | 2007-05-21 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007049630A1 (de) | 2007-10-11 | 2009-10-29 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007032800A1 (de) | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
EP2070909A1 (de) | 2007-12-15 | 2009-06-17 | Bayer Schering Pharma AG | Nichtsteroidale Progesteronrezeptor-Modulatoren |
CN113801889B (zh) * | 2021-09-18 | 2023-04-07 | 中国农业科学院农业质量标准与检测技术研究所 | 细胞筛选模型及其构建方法和应用、酵母菌及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8617653D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
DE4235220A1 (de) * | 1992-10-13 | 1994-06-16 | Schering Ag | Gestagen wirksame 19,11ß-überbrückte 4-Estrene |
DE4337416A1 (de) * | 1993-10-27 | 1995-05-04 | Schering Ag | 10,11beta-C¶2¶-überbrückte Steroide |
US5506102A (en) * | 1993-10-28 | 1996-04-09 | Ligand Pharmaceuticals Incorporated | Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription |
DE4413185A1 (de) * | 1994-04-12 | 1995-10-19 | Schering Ag | 11beta,19-überbrückte 13alpha-Alkylsteroide |
DE19723722A1 (de) * | 1997-05-30 | 1998-12-10 | Schering Ag | Nichtsteroidale Gestagene |
-
2001
- 2001-12-21 WO PCT/EP2001/015200 patent/WO2002054064A2/en active Application Filing
- 2001-12-21 EP EP01272662A patent/EP1373888A2/en not_active Ceased
- 2001-12-21 AU AU2002219218A patent/AU2002219218A1/en not_active Abandoned
- 2001-12-21 JP JP2002554712A patent/JP2004516841A/ja active Pending
- 2001-12-26 AR ARP010106030A patent/AR032050A1/es not_active Application Discontinuation
- 2001-12-28 UY UY27107A patent/UY27107A1/es not_active Application Discontinuation
- 2001-12-28 PE PE2001001311A patent/PE20020784A1/es not_active Application Discontinuation
-
2003
- 2003-06-27 NO NO20032969A patent/NO20032969L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY27107A1 (es) | 2002-03-22 |
NO20032969L (no) | 2003-08-28 |
JP2004516841A (ja) | 2004-06-10 |
NO20032969D0 (no) | 2003-06-27 |
PE20020784A1 (es) | 2002-10-03 |
EP1373888A2 (en) | 2004-01-02 |
WO2002054064A3 (en) | 2003-10-16 |
AU2002219218A1 (en) | 2002-07-16 |
WO2002054064A2 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007067A (es) | Sistema de medicion de analitos que previene la reutilizacion de una tira de prueba. | |
Alaudinova et al. | Use of phrasal verbs in tests on medical disciplines | |
ECSP099619A (es) | Anticuerpos anti-robo4 y sus usos | |
AR013671A1 (es) | Dispositivo de ensayo para la determinacion de substancias a analizar en un producto dietario liquido, procedimiento para la deteccion de substancias a analizar en un producto dietario y kit de ensayo que comprende dicho dispositivo | |
MXPA05007065A (es) | Metodo para prevenir la reutilizacion en un sistema de medicion de analito. | |
ECSP088298A (es) | Modulacion de la expresion del receptor glucocorticoide | |
AR032050A1 (es) | Metodo para identificar ligandos de receptores de progesterona especificos para isoformas y ligandos de receptores de progesterona selectivos para tejidos | |
ES2190727B1 (es) | Dispositivo para formar y/o aumentar el numero relativo de celulas indiferenciadas en una poblacion celular y procedimientos correspondientes. | |
EP1789793A4 (en) | COMBINED TEST FOR DETECTION OF ALCOHOL AND DRUGS | |
SV2011003840A (es) | Metodos, sistemas y productos para predecir la respuesta de las celulas tumorales a un agente terapeutico y tratar un paciente de acuerdo con la respuesta predicha | |
ECSP077233A (es) | Moduladores del receptor de progesterona que comprenden los derivados del pirrol-oxindol y los usos de los mismos | |
WO2014036495A3 (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
GB2462764A (en) | Ex vivo methods for validating substance testing with human organs and or tissues | |
EA200901055A1 (ru) | Новый способ производства кексов | |
TW200720648A (en) | Oxidation-resistant indicator macromolecule | |
Nienkemper et al. | Orthodontic mini-implant stability at different insertion depths | |
Bonifácio et al. | Micro-mechanical bond strength tests for the assessment of the adhesion of GIC to dentine | |
AR048135A1 (es) | Uso de gen de amiloide a serico en el diagnostico y tratamiento del glaucoma y en la identificacion de agentes anti-glaucoma. | |
DE69721021D1 (de) | Blasenmukosa mit zellen für die rekonstruktion von geweben | |
ATE350662T1 (de) | Markerproteine für prostatakrebs | |
RS20100249A (en) | CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE | |
ES2685503T3 (es) | Métodos de medida de la división in vivo de Factor von Willebrand mediada por ADAMTS13 y utilización de los mismos | |
ES2167625T3 (es) | Telas no tejidas de grafito como capas funcionales en estuches para pruebas diagnosticas. | |
WO2004037160A3 (en) | In vitro test for studying compound predicting pharmacologic and/or pharmacokinetic and/or pharmacodynamic parameters of a compound | |
BRPI0209172B8 (pt) | método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |